Comprehensive intermediate and near vision testing with trifocal intraocular lenses

Not Applicable

Completed

• Conditions: Vision of pseudophakic patients implanted with trifocal IOLs; Eye Diseases

• Registration Number: ISRCTN43094282
• Lead Sponsor: Ocular Technology Group International

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-10-31
• Study Start: 2020-03-10
• Last Update Posted: 30 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. At least 18 years of age
2. Have read and understood the Participant Information Sheet and gave Informed Consent
3. Pseudophakic successfully implanted with AcrySof® PanOptix (TFNT00) or RayOne Trifocal by Rayner or Fine Vision Trifocal by PhysIOL IOLs bilaterally for at least 3 months but no longer than 24 months
4. Best-corrected visual acuity of at least +0.20 logMAR (20/32) in each eye
5. Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule

Exclusion Criteria

1. Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate study participation
2. History of any ocular surgical procedures or surgeries other than cataract surgery including but not limited to limbal relaxing incision (LRI), astigmatic keratotomy, laser-assisted in situ keratomileusis (LASIK), and retinal laser treatment
3. Use of systemic or ocular medications that could be contraindicated as determined by the investigator
4. Any moderate or severe ocular condition observed during the slit-lamp examination prior to study vision measurements
5. Known pregnancy or lactation during the study period

Study & Design

• Study Type: Interventional
• Study Design: Not specified